Booming Prosthesis Plant In Parsippany Paid Visit By Rep. Sherrill

PARSIPPANY, NJ — This week, U.S. Rep. Mikie Sherrill visited a growing medical technology company in Parsippany to commemorate the one-year anniversary of the CHIPS and Science Act.

The federal CHIPS Act, which Sherrill supported, provided $53 million for high-tech research and manufacturing projects in the United States.

In just one year, the United States economy has seen $231 billion in private investment in the semiconductor industry, as well as the highest number of manufacturing jobs in New Jersey since the early 1990s.

Since then, Sherrill has held roundtables and listening tours with New Jersey businesses to discuss the legislation's impact.

On Tuesday, Sherrill took advantage of some spare time and visited Onkos Surgical, a manufacturer of bone and joint prosthetic implants that relocated its headquarters and manufacturing to Morris County eight years ago.

Onkos Surgical, located at 77 E. Halsey Road in Parsippany, has expanded its expertise in innovative 3D printing and surgical planning for musculoskeletal oncology.

At this facility, Onkos will now manufacture high-tech prostheses for children with sarcoma, a cancer of the bones and soft tissue.

"New Jersey’s spirit of innovation powers our economy, creates good-paying jobs, and improves working families’ quality of life. Onkos is continuing that legacy as manufacturing and R&D work for this new product gets underway at their newly expanded facility here in NJ-11," Sherrill said.

Onkos was founded in 2015 with a focus on sarcoma and other rare and complex musculoskeletal cancers. Since then, they have been revolutionizing the treatment of musculoskeletal cancer and complex orthopedic conditions.

"Congresswoman Sherrill has advocated for policies that support companies of our size to continue funding innovation for surgeons and patients. I would also like to recognize Dr. Kathleen Beebe from Rutgers New Jersey Medical School for her stewardship of the orthopedic oncology specialty. Collectively, these efforts are critical to the innovation we are pursuing to advance sarcoma care for adult and pediatric patients," Patrick Treacy, Onkos Surgical Founder and CEO, said.

Recently, the company introduced Onkos' JTS Extendible Prosthesis, a lower-leg implant designed for pediatric patients with bone cancer. The implant uses magnetic technology to expand non-invasively to accommodate the patient's natural growth curve, preserving lower limb length equality in young cancer patients.

According to the company, the addition of JTS technology broadens their access and ability to provide pediatric patient solutions.

"Our investment in manufacturing innovation and design expertise will make a big difference in the future for these surgeons, patients, and families, and we couldn’t be more proud to serve their needs," Treacy said.

The tour served as a commemoration of the one-year anniversary of the federal CHIPS Act, which aimed to strengthen American competitiveness and national security by investing in advanced R&D and domestic manufacturing.

The legislature's goal was to improve competition with China and other foreign adversaries.

"It is always exciting and encouraging to see manufacturing jobs return to the U.S. as we work to strengthen our economy for both New Jersey workers and job creators, and I had a great discussion today with Onkos employees about the strong future ahead for American manufacturing and R&D," Sherrill said.